CSPC Pharmaceutical, AstraZeneca Sign AI-Led Research Deal for Pre-Clinical Candidates for Chronic Conditions

Published on 2025-06-13 at 05:59

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical's Mesalazine Tablets Receive Drug Registration in China; Shares Fall 2%	07-06	MT
CSPC Pharmaceutical Group Limited Announces Mesalazine Enteric-Coated Tablets Obtains Drug Registration Approval from National Medical Products Administration of the People's Republic of China	07-04	CI
CSPC Pharmaceutical Gets Clinical Trial Nod for Methylmalonic Acidemia Drug in China	07-03	MT
CSPC Pharmaceutical Group Limited Announces High-Concentration Hydroxocobalamin Hydrochloride Injection Obtains Approval from the National Medical Products Administration of the People's Republic of China	07-03	CI
Ascletis' GLP-1 Compound Patent Challenged in US by CSPC Pharma Unit	06-30	MT
CSPC Pharmaceutical Group Limited Announces Change in Composition of Nomination Committee, Effect from 27 June 2025	06-27	CI
CSPC Pharmaceutical Group Limited Announces Meloxicam Injection Obtains Drug Registration Approval	06-23	CI
CSPC Pharma Gets China Nod for Meloxicam Injection	06-22	MT
Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$10.22 From HK$8.02, Keeps at Buy	06-16	MT
AstraZeneca signs AI research deal with China's CSPC for chronic diseases	06-13	RE
CSPC Pharmaceutical, AstraZeneca Sign AI-Led Research Deal for Pre-Clinical Candidates for Chronic Conditions	06-13	MT
AstraZeneca Enters Strategic Collaboration with CSPC Pharmaceuticals Group Limited	06-13	CI
AstraZeneca Teams Up With CSPC Pharmaceuticals With Deal Valued at Up to $5.33 Billion	06-13	DJ
AstraZeneca boosts China ties with up to USD5.3 billion partnership	06-13	AN
AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC	06-13	RE
CSPC Pharmaceutical Enters Into Strategic Research Collaboration Agreement With AstraZeneca	06-13	RE
Astrazeneca Enters Collaboration Worth Up To $5.22 Bln With CSPC Pharmaceuticals	06-13	RE
CSPC Pharmaceutical Gets US FDA Nod for Tumor Drug Trial	06-10	MT
Cspc Pharmaceutical's Sys6040 Obtains Clinical Trial Approval In U.S.	06-10	RE
Cspc Pharmaceutical Group Limited Announces Sys6040 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval in the U.S	06-10	CI
CSPC Pharmaceutical Gets China Nod for Registration of Anemia Drug	06-05	MT
CSPC Pharmaceutical Says Cobamamide Capsules Obtain Drug Registration Approval From NMPA	06-05	RE
CSPC Pharmaceutical Group Limited Announces Cobamamide Capsules Obtains Drug Registration Approval	06-05	CI
CSPC Pharmaceutical Says JMT101 Granted Breakthrough Therapy Designation For Treatment Of Colorectal Cancer by NMPA	06-02	RE
CSPC Pharmaceutical Gets Chinese Breakthrough Therapy Designation for Colorectal Cancer Drug	06-02	MT

CSPC PHARMACEUTICAL GROUP LIMITED

Stock

1093

HK1093012172

Delayed Hong Kong S.E. Other stock markets 03:56:21 2025-07-18 EDT
9.170 ^HKD	+2.34%

More quotes

Chart

Duration

Period

1093: Dynamic Chart

Income Statement and Estimates

More financial data

Headlines

Employment figures offer some respite for the Bank of England

Results preview: Legrand accelerates

July 17, 2025 at 05:51 am

Crypto companies face the fatal trap of Bitcoin - Crypto roundup

July 17, 2025 at 05:24 am

When volatility boosts US banks

July 17, 2025 at 04:42 am

Shorting the dollar: the most popular trade amongst fund managers

July 17, 2025 at 03:20 am

The Week's Biggest Mergers Unpacked

July 16, 2025 at 10:12 am

Diageo reshuffles its management team: Nik Jhangiani temporarily replaces Debra Crew

July 16, 2025 at 09:29 am

How did Indonesia go from 32% to 19% customs tariffs?

July 16, 2025 at 09:23 am

Rare earths: Apple joins the industrial front supported by the Pentagon

July 16, 2025 at 06:16 am

Is Scott Bessent the ideal candidate to succeed Jerome Powell?

July 16, 2025 at 06:06 am

All our articles